Lailitifa Windy Subekti 22010111130116 Lap.KTI Bab8

DAFTAR PUSTAKA

1. Sinatra RS, Jahr JS, Watkins-Pitchford JM, editors. The Essence of Analgesia and Analgesics. Cambridge: Cambridge University Press; 2011. p. 229-231. 2. Laine L. Approaches to nonsteroidal anti-inflammatory drug use in the

high-risk patient. Gastroenterology. 2001; 120:594-606.

3. IMS Health. IMS MIDAS Quantum based on selected markets (ATC = M1A oral solids form only. US$ Actual, growth in US$ CER). Q4. 2008.

4. Kementerian Kesehatan Republik Indonesia. Riset Kesehatan Dasar (RISKESDAS) 2013. Jakarta: Badan Penelitian dan Pengembangan Kesehatan; 2013.

5. Kementerian Kesehatan Republik Indonesia. Riset Kesehatan Dasar (RISKESDAS) 2007. Jakarta: Badan Penelitian dan Pengembangan Kesehatan; 2007.

6. Meinicke J, Danneskiold-Samsøe B. Diclofenac sodium (Voltaren) and ibuprofen in rheumatoid arthritis. A randomized double-blind study. Scand J Rheumatol Suppl. 1980; 35:1-8.

7. Burke A, Smyth E, FitzGerald GA. Analgesic-Antipyretic Agents; Pharmacotherapy of Gout. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gillman’s The Pharmacological Basis of Therapeutics. 12th ed. California: The McGraw Hill Companies; 2011. p. 698.

8. Aronson, JK. Meyler's Side Effects of Analgesics and Anti-inflammatory Drugs. San Diego: Elsevier Science 702; 2010. p. 225-226.

9. Griffin MR, Yared A, Ray WA. Nonsteroidal antiinflammatory drugs and acute renal failure in elderly persons. American Journal of Epidemiology. 2000; 151:488–496.

10. Harris RC. COX-2 and the Kidney. Journals of Cardiovascular Pharmacology. 2006; 47:S37–S42.

11. Satoskar RS, Bhandarkar SD, Rege NN. Pharmacology and Pharmacotherapeutics 21st ed. Mumbai: Popular Prakashan; 2009.

12. Koepke JA, Koepke JF. Guide to Clinical Laboratory Diagnosis. Michigan: Appleton & Lange; 1987.

13. Ronco C, Bellomo R, Kellum JA. Critical Nephrology 2nd ed. Philadelphia: Saunders Elsevier; 2009. p. 252-254.

14. Yasmeen T, Qureshi GS, Perveen S. Adverse effects of Diclofenac sodium on renal parenchyma of adult albino rats. Jinnah Postgraduate Medical Journal. 2007; 57(7):349-351.

15. Taib NT, Jarrar BM, Mubarak MM. Ultrastructural Alterations in Renal Tissues of Rabbits Induced by Diclofenac Sodium (Voltaren). Saudi Med J. 2004; 25(10):1360-1365.

16. Aprioku JS, Uche FI. Renal Effects of Non-Steroidal Anti-Inflammatory Drugs in Albino Rats. British Journal of Pharmaceutical Research. 2013; 3(3): 314-325.

17. Payne RB. Tests of Kidney Function. Scientific Foundations of Biochemistry in Clinical Practice. 1994; 325-337.

18. Jacobson RH, Striker EG, Klahrs S. The Principles and Practice of Nephrology. Philadelphia: Decker Inc; 1991.

19. Witjaksono, Villyastuti YW, Sutiyono D. Masalah Nyeri. In: Soenarjo, Jatmiko HD, editors. Anestesiologi ed 2. Semarang: PERDATIN Cabang Jawa Tengah; 2013. hal. 309-321.

20. Dorland. Dorland’s Illustrated Medical Dictionary. 32nd ed. Philadelphia: Elsevier Saunders; 2012. p. 252-254, 403-407.

21. International Association for the Study of Pain. IASP Taxonomy [Internet]. c2015 [updated 2012 May 22; cited 2015 Jan 9]. Available from: http://www.iasp-pain.org/Taxonomy/

22. Bull E, Archard G. Simple Guide Nyeri Punggung. Jakarta: Penerbit Erlangga; 2007. hal. 11.

23. World Health Organization (WHO) Ladder [Internet]. Iowa City: Geriatric Pain; 2015 [updated 2014; cited 2015 Jan 9]. Available from: http://www.geriatricpain.org/Content/Management/Interventions/Documents/ WHO%20ladder.pdf/

24. Parnham MJ. Non Opioid Analgesic in the Treatment of Acute Pain. Sweden: Springer Basel AG; 2012.

25. Ganiswarna SG, editor. Farmakologi dan Terapi ed 5. Jakarta: Balai Penerbit FK UI; 2012. hal. 208, 218.

26. Katzung BG. Farmakologi Dasar dan Klinik. Jakarta: Salemba Medika; 2004. hal. 688-689.

27. Witjahjo RBB. Sistem Urinarius. In: Susilaningsih N, Ismail A, Armalina D, Saktini F, editors. Lecture Notes Histologi 2. Semarang: Bagian Histologi Fakultas Kedokteran Universitas Diponegoro; 2012. hal. 68-82.

28. Guyton AC, Hall JE. Buku Ajar Fisiologi Kedokteran Edisi 11. Jakarta: EGC; 2007. hal. 324-326.

29. Van de Graff. Human Anatomy 6th Edition. California: The McGraw Hill Companies; 2001. p. 677.

30. Faiz O, Moffat D. Anatomi at a Glance. Oxford: Blackwell Science; 2002. p. 49.

31. Ellis H. Clinical Anatomy Applied anatomy for students and junior doctors 11th Edition. Oxford: Blackwell Science; 2006. p. 105-107.

32. Anatomy & Physiology [cited 2015 26 Jan]. Available from: http://philschatz.com/anatomy-book/contents/m46429.html.

33. Bagian Anatomi. Systema Urogenital. Semarang: Bagian Anatomi Fakultas Kedokteran Universitas Diponegoro. hal 1-9.

34. Harris RC, Neilson EG. Adaptation of the Kidney to Renal Injury. In: Longo DL, Fauci AS, Loscalzo J, Hauser SL et al, editors. Harrison’s Principle of Internal Medicine. 18th ed. California: The McGraw Hill Companies; 2011. p. 2289.

35. Junqueira LC, Carneiro J. Basic Histology. California: The McGraw Hill Companies; 2002. p. 332-342.

36. Sherwood L. Human Physiology From Cells to Systems. California: Yolanda Cossio; 2010. p. 512.

37. Effendi I, Markum HMS. Pemeriksaan Penunjang pada Penyakit Ginjal. In: Sudoyo AW, Setiyohadi B, Alwi I, Simadibrata M, Setiati S, editors. Buku Ajar Ilmu Penyakit Dalam. ed 5. Jakarta: Interna Publishing; 2009. hal. 938. 38. Selim MI. Ammonia, Urea Biosynthesis, Ammonia Intoxication [published

lecture notes]. Available from:

http://osp.mans.edu.eg/medbiochem_mi/Cources/Biochemistry/2nd_year_med icine/Protein_metabolism/files/Lecture_03.htm/

39. Murray RK, Granner DK, Rodwell VW, Mayes PA. Harper’s Illustrated Biochemistry 26th ed. California: The McGraw Hill Companies; 2003. p. 260. 40. Blood Serum Chemistry - Normal Values [Internet]. Maryland: US FDA;

2015 [updated 2015 Jan 8; cited 2015 Jan 12]. Available from: http://www.fda.gov/downloads/ICECI/Inspections/IOM/UCM135835.pdf/ 41. Weir MR. Renal Effects of Nonselective NSAIDs and Coxibs. Cleveland

Clinic Journal of Medicine [Internet]. 2002. [cited 2014 October 4]; 69(1):53. Available from: PubMed.

42. Modi CM, Mody SK, Patel HB, Dudhatra GB, Kumar A, Avale M. Toxicopathological overview of analgesic and anti-inflammatory drugs in animals. Journal of Applied Pharmaceutical Science [Internet]. 2012. [cited 2015 January 8]; 02(01):149-157. Available from: www.japsonline.com. 43. Are cyclooxygenase-2-selective inhibitors safe for the kidneys? Joint Bone

Spine [Internet]. 2013 [cited 2015 January 8]; 70(2013):237-241. Available from: www.sciencedirect.com.

44. Musu M et al. Acute nephrotoxicity of NSAID from the foetus to the adult. European Review for Medical and Pharmacological Sciences [Internet]. 2011 [cited 2015 January 8]; 15(2011):1461-1472. Available from: www.sciencedirect.com.

45. Claria J, Arroyo V. Prostaglandins and other cyclooxygenase-dependent arachidonic acid metabolites and the kidney in liver disease. Prostaglandins & other Lipid Mediators [Internet]. 2003 [cited 2015 January 8]; 72(2003):19-33. Available from: www.sciencedirect.com.

46. UpToDate [Internet]. NSAID: Acute renal failure and nephrotic syndrome; c2001 [updated 2001 May 10; cited 2015 January 8]. Available from: www.uptodate.com.

47. Naughton CA. Drug-Induced Nephrotoxicity. American Family Physician [Internet]. 2008 [cited 2015 January 8]; 78(6):743-750. Available from: www.aafp.org/afp.

48. Kumar V, Cotran RS, Robbins SL. Buku Ajar Patologi Robbins Volume 1. Jakarta: Penerbit Buku Kedokteran EGC; 2004. hal. 8-9.

49. World Health Organization (WHO). General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine. Geneva: WHO. 2000. 50. Laurence DR et al. Evaluation of Drug Activities. London: Academic Press.

1964.

51. Dilger K et al. Effects of celecoxib and diclofenac on blood pressure, renal function, and vasoactive prostanoids in young and elderly subjects. J Clin Pharmacol [Internet]. 2002 [cited 2015 June 11]: 42(9):985-994. Available from: www.ncbi.nlm.nih.gov/pubmed.

52. Evenepoel P. Acute toxic renal failure. Best Practice & Research Clinical Anaesthesiology [Internet]. 2004 [cited 2015 June 8]: 18(1):37-52. Available from: www.sciencedirect.com.

53. Bolat D, Selcuk ML. Stereological and biochemical evaluation of diclofenac-induced acute nephrotoxicity in rats. Revue Med. Vet. [Internet]. 2013 [cited 2015 January 8]: 164(6):290-294. Available from: www.revmedvet.com. 54. U.S. National Library of Medicine [Internet]. Maryland: U.S. National Library

of Medicine; c1993 [updated 2015 June 19; cited 2015 June 29]. Available from: http://www.nlm.nih.gov.

55. Brenner BM. Brenner & Rector’s The Kidney Volume 1 8th ed. Philadelphia: Saunders Elsevier; 2008. p. 783-786.

LAMPIRAN

LAMPIRAN 3. DATA PENELITIAN

Kelompok Tikus Ke- Kadar Ureum (mg/dl)

Kontrol 1

2 3 4 5

51,8 49,9 60,1 68,9 66,0

Perlakuan 1 1

2 3 4 5

50 52,4 57,4 84,3 75,3

Perlakuan 2 1

2 3 4 5

65,1 66,4 48,4 77,3 56,9

LAMPIRAN 4. HASIL ANALISIS

Case Processing Summary

Dosis Natrium Diklofenak Cases

Valid Missing Total

N Percent N Percent N Percent

Kadar Ureum

.00 5 100.0% 0 0.0% 5 100.0%

1.40 5 100.0% 0 0.0% 5 100.0%

2.80 5 100.0% 0 0.0% 5 100.0%

Descriptives

Dosis Natrium Diklofenak Statistic Std. Error

Kadar Ureum

.00

Mean 59.3400 3.75694

95% Confidence Interval for Mean

Lower Bound 48.9091

Upper Bound 69.7709

5% Trimmed Mean 59.3333

Median 60.1000

Variance 70.573

Std. Deviation 8.40077

Minimum 49.90

Maximum 68.90

Range 19.00

Interquartile Range 16.60

Skewness -.071 .913

Kurtosis -2.606 2.000

1.40

Mean 63.8800 6.75954

95% Confidence Interval for Mean

Lower Bound 45.1125

Upper Bound 82.6475

5% Trimmed Mean 63.5167

Median 57.4000

Variance 228.457

Std. Deviation 15.1147 9

Minimum 50.00

Range 34.30

Interquartile Range 28.60

Skewness .669 .913

Kurtosis -2.081 2.000

2.80

Mean 62.8200 4.85112

95% Confidence Interval for Mean

Lower Bound 49.3511

Upper Bound 76.2889

5% Trimmed Mean 62.8167

Median 65.1000

Variance 117.667

Std. Deviation 10.8474 4

Minimum 48.40

Maximum 77.30

Range 28.90

Interquartile Range 19.20

Skewness -.037 .913

Kurtosis .001 2.000

Tests of Normality

Dosis Natrium Diklofenak

Kolmogorov-Smirnova Shapiro-Wilk Statistic df Sig. Statistic df Sig.

Kadar Ureum

.00 .215 5 .200* .913 5 .487 1.40 .266 5 .200* .878 5 .300 2.80 .183 5 .200* .982 5 .946

Test of Homogeneity of Variances

Kadar Ureum

Levene Statistic df1 df2 Sig.

1.982 2 12 .180

ANOVA

Kadar Ureum

Sum of Squares df Mean Square F Sig.

Between Groups 56.409 2 28.205 .203 .819 Within Groups 1666.788 12 138.899

Total 1723.197 14

Post Hoc Tests

Multiple Comparisons

Dependent Variable: Kadar Ureum LSD

(I) Dosis Natrium Diklofenak

(J) Dosis Natrium Diklofenak

Mean Difference (I-J)

Std. Error Sig. 95% Confidence Interval

Lower Bound Upper Bound

.00

1.40 -4.54000 7.45383 .554 -20.7805 11.7005

2.80 -3.48000 7.45383 .649 -19.7205 12.7605

1.40 .00 4.54000 7.45383 .554 -11.7005 20.7805 2.80 1.06000 7.45383 .889 -15.1805 17.3005

2.80

.00 3.48000 7.45383 .649 -12.7605 19.7205

LAMPIRAN 6. BIODATA MAHASISWA

Identitas

Nama : Lailitifa Windy Subekti

NIM : 22010111130116

Tempat/tanggal lahir : Kebumen/22 Januari 1994 Jenis Kelamin : Perempuan

Alamat : Dukuh Srasutan, RT 02/01, Desa Ungaran, Kec. Kutowinangun, Kab. Kebumen

Nomor Telepon : -

Nomor HP : 085643308874

e-mail : lailitifawindy@gmail.com

Riwayat Pendidikan Formal

1. SD : SD N 1 Ungaran Lulus tahun: 2005

2. SMP : SMP N 1 Kebumen Lulus tahun: 2008

3. SMA : SMA N 1 Kebumen Lulus tahun: 2011

4. FK UNDIP : Masuk tahun : 2011

Keanggotaan Organisasi

1. Sekretaris As-Syifa Medical Team Tahun 2013 s/d sekarang 2. Staf Bidang Diklat HIMA KU Undip Tahun 2012 s/d 2014 3. Staf Bidang KSKI Rohis KU Undip Tahun 2012 s/d 2014

4. Staf Bidang PMP KSM Undip Tahun 2013 s/d 2014

LAMPIRAN 3. DATA PENELITIAN

Kelompok

Tikus Ke-

Kadar Ureum (mg/dl)

Kontrol

1

2

3

4

5

51,8

49,9

60,1

68,9

66,0

Perlakuan 1

1

2

3

4

5

50

52,4

57,4

84,3

75,3

Perlakuan 2

1

2

3

4

5

65,1

66,4

48,4

77,3

56,9

LAMPIRAN 4. HASIL ANALISIS

Case Processing Summary

Dosis Natrium Diklofenak Cases

Valid Missing Total N Percent N Percent N Percent

Kadar Ureum

.00 5 100.0% 0 0.0% 5 100.0%

1.40 5 100.0% 0 0.0% 5 100.0% 2.80 5 100.0% 0 0.0% 5 100.0%

Descriptives

Dosis Natrium Diklofenak Statistic Std. Error

Kadar Ureum

.00

Mean 59.3400 3.75694

95% Confidence Interval for Mean

Lower Bound 48.9091 Upper Bound 69.7709 5% Trimmed Mean 59.3333

Median 60.1000

Variance 70.573

Std. Deviation 8.40077

Minimum 49.90

Maximum 68.90

Range 19.00

Interquartile Range 16.60

Skewness -.071 .913

Kurtosis -2.606 2.000

Range 34.30 Interquartile Range 28.60

Skewness .669 .913

Kurtosis -2.081 2.000

2.80

Mean 62.8200 4.85112

95% Confidence Interval for Mean

Lower Bound 49.3511 Upper Bound 76.2889 5% Trimmed Mean 62.8167

Median 65.1000

Variance 117.667

Std. Deviation 10.8474

4

Minimum 48.40

Maximum 77.30

Range 28.90

Interquartile Range 19.20

Skewness -.037 .913

Kurtosis .001 2.000

Tests of Normality

Dosis Natrium Diklofenak

Kolmogorov-Smirnova Shapiro-Wilk Statistic df Sig. Statistic df Sig.

Kadar Ureum

.00 .215 5 .200* .913 5 .487 1.40 .266 5 .200* .878 5 .300 2.80 .183 5 .200* .982 5 .946

Test of Homogeneity of Variances

Kadar Ureum

Levene Statistic df1 df2 Sig. 1.982 2 12 .180

ANOVA

Kadar Ureum

Sum of Squares df Mean Square F Sig. Between Groups 56.409 2 28.205 .203 .819 Within Groups 1666.788 12 138.899

Total 1723.197 14

Post Hoc Tests

Multiple Comparisons

Dependent Variable: Kadar Ureum LSD

LAMPIRAN 6. BIODATA MAHASISWA

Identitas

Nama

: Lailitifa Windy Subekti

NIM

: 22010111130116

Tempat/tanggal lahir : Kebumen/22 Januari 1994

Jenis Kelamin

: Perempuan

Alamat

: Dukuh Srasutan, RT 02/01, Desa Ungaran, Kec.

Kutowinangun, Kab. Kebumen

Nomor Telepon

: -

Nomor HP

: 085643308874

e-mail

: lailitifawindy@gmail.com

Riwayat Pendidikan Formal

1.

SD

: SD N 1 Ungaran

Lulus tahun: 2005

2.

SMP

: SMP N 1 Kebumen

Lulus tahun: 2008

3.

SMA

: SMA N 1 Kebumen

Lulus tahun: 2011

4.

FK UNDIP

: Masuk tahun : 2011

Keanggotaan Organisasi

1.

Sekretaris As-Syifa Medical Team

Tahun 2013 s/d sekarang

2.

Staf Bidang Diklat HIMA KU Undip

Tahun 2012 s/d 2014